Study documentation part: Visits 1 (Screening), Study week -4 to 0 Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.r: NCT02461069.

Versions (3) ▾
  1. 9/17/15
  2. 9/22/15
  3. 5/24/16
Uploaded on:

May 24, 2016

No DOI assigned. To request one pleaselog in.
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Visit 1 (Screening) Part 1/2, DIMAT-MS, Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069

Blood samples for safety laboratory tests

Date of blood sampling
Leucocytes measurement unit
Leucocytes Me
Lymphocytes measurement unit
Lymphocytes Count Procesdure not done
Liver Function
AST Measurement Unit
AST measurement not done
GGT Measurement Unit
GGT Measurement not done
Renal function
Serum Creatinine Measurment Unit
Serum Creatinine Measurment not done